TuHURA Biosciences, Inc./NV (HURA) Institutional Ownership

Ownership Summary

TuHURA Biosciences, Inc./NV (NASDAQ:HURA) appears in 63 institutional 13F filings for the quarter ending December 2025.

• These investors held 12.9% of outstanding shares in December 2025, up from 12.1% in September 2025.
• They increased total shares held in HURA by 8.85% quarter over quarter, and investors in TuHURA Biosciences increased 125.0% from a year ago.
• During the quarter, 36 of these 63 funds increased positions in HURA, 13 reduced exposure, and 14 held steady.
• Institutional investors collectively held 6.55Mn shares in TuHURA Biosciences as of December 2025, up by 532.47K shares quarter on quarter, and up 4.37Mn shares year over year.
• BlackRock, Inc. is the top holder of TuHURA Biosciences as of December 31, 2025, with 2.45Mn shares representing 4.84% of outstanding stock.
• The biggest buyers of TuHURA Biosciences for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (2.07Mn), BlackRock, Inc. (883.89K), AQR CAPITAL MANAGEMENT LLC (590.67K), GEODE CAPITAL MANAGEMENT, LLC (324.44K), VANGUARD FIDUCIARY TRUST CO (287.13K).
• The largest sellers of TuHURA Biosciences for the quarter ending December 2025 were Morgan Stanley (152.36K), Suncoast Equity Management (104.41K), Barclays Plc (43.37K), Wells Fargo & Company/Mn (20.76K), Cyndeo Wealth Partners, LLC (20.44K).
• According to Business Quant data, leading holders of HURA for December 2025 are BlackRock, Inc. (2.45Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.07Mn), GEODE CAPITAL MANAGEMENT, LLC (986.92K), AQR CAPITAL MANAGEMENT LLC (607.17K), State Street Corp (512.91K), Northern Trust Corp (298.19K), VANGUARD FIDUCIARY TRUST CO (287.13K), VANGUARD PORTFOLIO MANAGEMENT LLC (253.64K), Bank of New York Mellon Corp (211.57K), Apollon Wealth Management, LLC (158.01K).